- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1041
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Practical risk management in early phase clinical trials ; day:19 ; month:12 ; year:2018 ; pages:1-14
European journal of clinical pharmacology ; (19.12.2018), 1-14
- Creator
-
Coates, Simon
Täubel, Jörg
Lorch, Ulrike
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00228-018-02607-8
- URN
-
urn:nbn:de:101:1-2019020400142485587462
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Coates, Simon
- Täubel, Jörg
- Lorch, Ulrike
- SpringerLink (Online service)
Other Objects (12)
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units
Precision Oncology for Cancer Immunotherapies in Early-Phase Clinical Trials
Design considerations for early-phase clinical trials of immune-oncology agents
Optimal Adaptive Designs for Early Phase II Trials in Clinical Oncology
Conducting clinical trials : a theoretical and practical guide
Ocular toxicity of investigational anti-cancer drugs in early phase clinical trials
Phase I Clinical Trials in Oncology
Social determinants of health inequalities in early phase clinical trials in Northern England
Changes in Early-Phase Clinical Trials in China During 2013–2022: A Review
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials
Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials
The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units
Precision Oncology for Cancer Immunotherapies in Early-Phase Clinical Trials
Design considerations for early-phase clinical trials of immune-oncology agents
Optimal Adaptive Designs for Early Phase II Trials in Clinical Oncology
Conducting clinical trials : a theoretical and practical guide
Ocular toxicity of investigational anti-cancer drugs in early phase clinical trials
Phase I Clinical Trials in Oncology
Social determinants of health inequalities in early phase clinical trials in Northern England
Changes in Early-Phase Clinical Trials in China During 2013–2022: A Review
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials
Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials
The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies
Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units
Precision Oncology for Cancer Immunotherapies in Early-Phase Clinical Trials
Design considerations for early-phase clinical trials of immune-oncology agents
Optimal Adaptive Designs for Early Phase II Trials in Clinical Oncology
Conducting clinical trials : a theoretical and practical guide
Ocular toxicity of investigational anti-cancer drugs in early phase clinical trials
Phase I Clinical Trials in Oncology
Social determinants of health inequalities in early phase clinical trials in Northern England
Changes in Early-Phase Clinical Trials in China During 2013–2022: A Review
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials
Tumor fraction-based prognostic tool for cancer patients referred to early phase clinical trials